Free Trial
NASDAQ:HCWB

HCW Biologics (HCWB) Stock Price, News & Analysis

HCW Biologics logo
$4.12 -0.05 (-1.20%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$4.09 -0.03 (-0.73%)
As of 07/8/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About HCW Biologics Stock (NASDAQ:HCWB)

Key Stats

Today's Range
$4.03
$4.22
50-Day Range
$3.75
$10.05
52-Week Range
$3.55
$100.80
Volume
27,405 shs
Average Volume
281,194 shs
Market Capitalization
$5.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$35.00
Consensus Rating
Buy

Company Overview

HCW Biologics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
66th Percentile Overall Score

HCWB MarketRank™: 

HCW Biologics scored higher than 66% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HCW Biologics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    HCW Biologics has only been the subject of 1 research reports in the past 90 days.

  • Read more about HCW Biologics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of HCW Biologics is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of HCW Biologics is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about HCW Biologics' valuation and earnings.
  • Percentage of Shares Shorted

    1.12% of the float of HCW Biologics has been sold short.
  • Short Interest Ratio / Days to Cover

    HCW Biologics has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HCW Biologics has recently decreased by 68.06%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    HCW Biologics does not currently pay a dividend.

  • Dividend Growth

    HCW Biologics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.12% of the float of HCW Biologics has been sold short.
  • Short Interest Ratio / Days to Cover

    HCW Biologics has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HCW Biologics has recently decreased by 68.06%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    HCW Biologics has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for HCW Biologics this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, HCW Biologics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $305,032.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    42.70% of the stock of HCW Biologics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 2.96% of the stock of HCW Biologics is held by institutions.

  • Read more about HCW Biologics' insider trading history.
Receive HCWB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter.

HCWB Stock News Headlines

HCW Biologics Inc News (HCWB) - Investing.com
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
See More Headlines

HCWB Stock Analysis - Frequently Asked Questions

HCW Biologics' stock was trading at $17.8440 at the start of the year. Since then, HCWB stock has decreased by 76.9% and is now trading at $4.12.

HCW Biologics Inc. (NASDAQ:HCWB) issued its quarterly earnings results on Thursday, May, 15th. The company reported ($0.05) earnings per share for the quarter.

HCW Biologics's stock reverse split on Friday, April 11th 2025.The 1-40 reverse split was announced on Tuesday, April 1st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, April 10th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

HCW Biologics (HCWB) raised $45 million in an initial public offering (IPO) on Tuesday, July 20th 2021. The company issued 5,600,000 shares at $8.00 per share. EF Hutton served as the underwriter for the IPO and Revere Securities was co-manager.

Shares of HCWB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that HCW Biologics investors own include Jiuzi (JZXN), Faraday Future Intelligent Electric (FFIE), AMC Entertainment (AMC), Kiora Pharmaceuticals (KPRX), Rallybio (RLYB), Adial Pharmaceuticals (ADIL) and Aridis Pharmaceuticals (ARDS).

Company Calendar

Last Earnings
5/15/2025
Today
7/09/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HCWB
CIK
1828673
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$35.00
Low Price Target
$35.00
Potential Upside/Downside
+749.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$30.02 million
Net Margins
-1,712.94%
Pretax Margin
-1,713.01%

Debt

Sales & Book Value

Annual Sales
$2.57 million
Price / Cash Flow
N/A
Book Value
($6.08) per share
Price / Book
-0.68

Miscellaneous

Free Float
825,000
Market Cap
$5.93 million
Optionable
Not Optionable
Beta
0.65
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:HCWB) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners